This Article Full Text Full Text (PDF) All Versions of this Article: 111/20/2565    most recent CIRCULATIONAHA.104.515445v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jneid, H. Articles by Bolli, R. Search for Related Content PubMed PubMed Citation Articles by Jneid, H. Articles by Bolli, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITROGLYCERIN Related Collections Other myocardial biology Cardiovascular Pharmacology Exercise/exercise testing/rehabilitation Chronic ischemic heart disease

(Circulation. 2005;111:2565-2571.)
© 2005 American Heart Association, Inc.

Exercise Physiology

Delayed Preconditioning-Mimetic Actions of Nitroglycerin in Patients Undergoing Exercise Tolerance Tests

Hani Jneid, MD; Mukul Chandra, MD; Motaz Alshaher, MD; Carlton A. Hornung, PhD; Xian-Liang Tang, MD; Massoud Leesar, MD; Roberto Bolli, MD

From the Institute of Molecular Cardiology (H.J., M.C., M.A., X.-L.T., M.L., R.B.) and the Department of Epidemiology and Clinical Investigation Sciences (C.A.H.), University of Louisville, Louisville, Ky.

Correspondence to Roberto Bolli, MD, Division of Cardiology, University of Louisville, Louisville, KY 40292. E-mail rbolli{at}louisville.edu

Received October 19, 2004; revision received January 31, 2005; accepted February 9, 2005.

Background— Nitroglycerin (NTG) induces delayed preconditioning (PC)-mimetic effects in animal models and in humans during coronary angioplasty. We tested the hypothesis that NTG mitigates ischemia and enhances functional capacity during an exercise tolerance test (ETT) in patients with coronary artery disease.

Methods and Results— Twenty-eight patients with stable angina and ischemia documented by a stress test were randomized in a double-masked, crossover design to receive a titrated intravenous infusion of NTG or normal saline over 4 hours. At 24 to 28 hours after study medication infusion, each patient underwent 2 ETTs separated by a 1-week washout period. Compared with control patients, pretreatment with NTG was associated with a dose-dependent increase in exercise duration averaging 40 seconds (412±19 versus 372±24 seconds, P=0.014) and an improvement in ECG manifestations of ischemia, as shown by a decrease in maximal ST-segment depression (1.84±0.14 versus 1.63±0.13 mm, P=0.011), sum of ST-segment depressions in 12 leads (7.64±1.01 versus 6.61±0.83 mm, P=0.027), and time to resolution of ST-segment depression (229±30 versus 207±28 s, P=0.018). These benefits occurred despite an increase in myocardial workload after NTG, as indicated by a higher peak rate-pressure product (24 492±1054 versus 22 536±1019 mm Hg/min, P=0.015).

Conclusions— NTG produces a late PC-mimetic effect that mitigates the ECG manifestations of ischemia during exercise and improves exercise capacity. To our knowledge, this is the first study to demonstrate that NTG can alleviate exercise-induced ischemia 24 hours after its administration, long after the hemodynamic effects have subsided. The finding that nitrate-induced late PC ameliorates a common manifestation of coronary artery disease has potentially significant implications for the management of this disorder and for the design of clinical trials.

Key Words: exercise • nitroglycerin • ischemia • angina • coronary disease

This article has been cited by other articles:

				T. Gori and J. D. Parker Nitrate-Induced Toxicity and Preconditioning: A Rationale for Reconsidering the Use of These Drugs J. Am. Coll. Cardiol., July 22, 2008; 52(4): 251 - 254. [Abstract] [Full Text] [PDF]

				R. M. Mentzer Jr, M. S. Jahania, and R. D. Lasley Myocardial Protection Card. Surg. Adult, January 1, 2008; 3(2008): 443 - 464. [Full Text]

				T. C. Zhao, G. Cheng, L. X. Zhang, Y. T. Tseng, and J. F. Padbury Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury Cardiovasc Res, December 1, 2007; 76(3): 473 - 481. [Abstract] [Full Text] [PDF]

				S. Dragoni, T. Gori, M. Lisi, G. Di Stolfo, A. Pautz, H. Kleinert, and J. D. Parker Pentaerythrityl Tetranitrate and Nitroglycerin, but not Isosorbide Mononitrate, Prevent Endothelial Dysfunction Induced by Ischemia and Reperfusion Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 1955 - 1959. [Abstract] [Full Text] [PDF]

				R. A. Kloner and S. H. Rezkalla Preconditioning, postconditioning and their application to clinical cardiology Cardiovasc Res, May 1, 2006; 70(2): 297 - 307. [Abstract] [Full Text] [PDF]

				R. Bolli and A. Abdel-Latif No Pain, No Gain: The Useful Function of Angina Circulation, December 6, 2005; 112(23): 3541 - 3543. [Full Text] [PDF]